3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Multiple Myeloma
49
Leukemia, Lymphocytic, Chronic, B-Cell
19
Lymphoma, Non-Hodgkin
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma
12
Recurrence
10
Lymphoma, Mantle-Cell
9
Lymphoma, Follicular
7
Leukemia, Myeloid, Acute
7
Waldenstrom Macroglobulinemia
6
Neoplasms, Plasma Cell
6
Myelodysplastic Syndromes
6
Lymphoma, B-Cell, Marginal Zone
6
Leukemia
6
Lymphoma, T-Cell, Peripheral
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Burkitt Lymphoma
4
Sezary Syndrome
3
Prostatic Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, T-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, B-Cell
3
Immunoblastic Lymphadenopathy
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Interventions
venetoclax
3
Imatinib Mesylate
3
ponatinib
2
nilotinib
2
Dasatinib
2
Azacitidine
2
zileuton
1
thymoglobulin
1
pulrodemstat besilate
1
posaconazole
1
emvododstat
1
Transplantation
1
Standard of Care
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone Acetate
1
Methylprednisolone
1
Lenalidomide
1
IMC-EB10
1
Homoharringtonine
1
HhAntag691
1
Hematopoietic Stem Cell Transplantation
1
Decitabine
1
Cytarabine
1
Cyclosporine
1
CC 401
1
BID protein, human
1
Antilymphocyte Serum
1
AVE9633
1
3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Leukemia, Myeloid
×
Lenalidomide
×
Clear all
NCT02370888
2020-01-27
UF-BMT-MRD-101
University of Florida
Phase 1
Terminated
11 enrolled
3 charts